LGBT Cancer Project

Lung Cancer Clinical Trials

A listing of Lung Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Mirati Research Site
Birmingham Alabama 35294-3300

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Mirati Research Site
Huntsville Alabama 35805-2606

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Birmingham Alabama 35249

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Birmingham Alabama 35233

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Birmingham Alabama 35294

A clinical research study of Porfimer sodium for the treatment of Non-small Cell Lung Cancer (NSCLC)

Birmingham Alabama 35205

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Birmingham Alabama 35205

A clinical trial to evaluate treatments using Nivolumab in combination with Ipilimumab for patients with Lung Cancer

Birmingham Alabama 35233

A clinical trial to evaluate treatments using TRC105 for patients with Lung Cancer, Non-Squamous Cell Lung Cancer (NSCLC)

Arizona

Phoenix Arizona 85016

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Phoenix Arizona 85016

A clinical trial to evaluate treatments using Nivolumab in combination with Ipilimumab for patients with Lung Cancer

Prescott Valley Arizona 86314

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Scottsdale Arizona 85258

A clinical research study of carboplatin, paclitaxel and paclitaxel poliglumex for the treatment of Lung Cancer

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Sedona Arizona 86336

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Tucson Arizona 85704

A clinical trial to evaluate treatments using Nivolumab in combination with Ipilimumab for patients with Lung Cancer

Arkansas

Mirati Research Site
Jonesboro Arkansas 72401

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Jonesboro Arkansas 72401

A clinical research study of darbepoetin alfa 500 mcg Q3W and placebo for the treatment of Non-Small Cell Lung Cancer, Anemia, Cancer or Lung Cancer

Little Rock Arkansas 72205

A clinical research study of darbepoetin alfa 500 mcg Q3W and placebo for the treatment of Non-Small Cell Lung Cancer, Anemia, Cancer or Lung Cancer

California

Mirati Research Site
Burbank California 91505

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Mirati Research Site
La Jolla California 92093

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Mirati Research Site
Loma Linda California 92354

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Mirati Research Site
Los Angeles California 90073

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Mirati Research Site
San Francisco California 94115

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Incyte Corporation
Whittier California

An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Mirati Research Site
Whittier California 90603

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Anaheim California 92801

A clinical research study of darbepoetin alfa 500 mcg Q3W and placebo for the treatment of Non-Small Cell Lung Cancer, Anemia, Cancer or Lung Cancer

Bakersfield California 93309

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Bakersfield California 93309

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Bellflower California 90706

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Burbank California 91505

A clinical research study of carboplatin, paclitaxel and paclitaxel poliglumex for the treatment of Lung Cancer

Duarte California 91010

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of Bone Metastases

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating NEO-PV-01, Nivolumab and Adjuvant

Encinitas California 92024

Patients are needed to participate in a clinical research study of TR(ACE) Assay Testing to evaluate Carcinoma, Non-Small-Cell Lung or Breast Neoplasms

Escondido California 92025-4404

A clinical research study of carboplatin, paclitaxel and paclitaxel poliglumex for the treatment of Lung Cancer

Fullerton California 92835

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

La Jolla California 92093

A clinical research study for the treatment of Non-Small Cell Lung Cancer

La Jolla California 92093

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

La Jolla California 92037-0845

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

La Jolla California 92037

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

La Jolla California 92093-0658

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Loma Linda California 92354

A Phase 1 clinical study for patients with Non-Small Cell Lung Cancer (NSCLC)

Long Beach California 90813

A Phase 1 clinical study for patients with Non-Small Cell Lung Cancer (NSCLC)

Los Agneles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90095

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Los Angeles California 90024

A clinical research study of darbepoetin alfa 500 mcg Q3W and placebo for the treatment of Non-Small Cell Lung Cancer, Anemia, Cancer or Lung Cancer

Los Angeles California 90024

A clinical trial to evaluate treatments for patients with Solitary Pulmonary Nodule or Multiple Pulmonary Nodules

Los Angeles California 90033

A clinical trial to evaluate treatments using INT230-6, anti-PD-1 and anti-PD-1 antibody for patients